Early-Treatment Stabilization Infrastructure for GLP-1 Clinics
8-Week Stabilization Pilot for Owner-Led GLP-1 Clinics
✓ No EMR integration required
✓ No workflow disruption for clinic teams
✓ No Protected Health Information (PHI) collected during the pilot
Because no PHI is collected, a Business Associate Agreement (BAA) is not required during pilot participation.
Structured retention validation for GLP-1 programs.
Limited to 6 owner-led GLP-1 clinics
RetentionHealth does not alter treatment protocols, prescribe medications, or make clinical recommendations.
All medical decisions remain entirely under the authority of the treating physician and clinic.
The platform operates as operational stabilization infrastructure, providing behavioral reinforcement tools and retention analytics during the early treatment phase.
Across GLP-1 clinics, one pattern continues to appear during the first weeks of treatment.
Patients often experience appetite changes, digestive shifts, and uncertainty about what is normal during dose escalation.
These moments typically happen between appointments, where clinics have limited visibility into how patients are actually stabilizing.
As GLP-1 programs grow, this early treatment window increasingly becomes an operational challenge:
RetentionHealth was designed to introduce a structured stabilization layer during this ramp-up phase, allowing clinics to observe engagement patterns and quantify retention impact without disrupting their existing workflow.
The pilot program exists to measure whether this structured support improves early-treatment stability in real clinical environments.
GLP-1 therapies now serve 15M+ patients in the United States, delivered through tens of thousands of medical weight-loss and longevity clinics across the United States.
While demand continues to grow, many clinics are discovering a consistent operational challenge during the first weeks of treatment.
During this ramp-up period, patients often experience:
For clinics, this early phase can become a visibility gap — where patient stability is unclear until the next appointment.
When instability goes unnoticed, clinics may see:
Most GLP-1 programs experience the highest patient drop-off during the first 8 weeks of treatment.
During this ramp-up phase, clinics commonly experience several operational challenges.
Patient drop-off early in treatment creates unpredictable monthly recurring revenue (MRR).
Patients frequently contact clinics with questions about appetite changes, digestion shifts, and dose escalation.
Teams spend time responding to patient concerns individually rather than operating within a structured monitoring system.
Early treatment instability can make medication refill patterns inconsistent, complicating inventory and cash flow planning.
Stopping early-phase churn has a disproportionately large impact on patient lifetime value.
In GLP-1 programs, small changes in early-treatment retention can have a meaningful impact on clinic revenue.
Illustrative Example
If stabilization monitoring reduces early drop-off by 10%, the clinic retains approximately:
12 additional patients
That represents roughly:
$7,200 in preserved monthly program revenue
or approximately
$86,400 in annualized patient value
Pilot Participation
Founder pilot rate:
$500 per month
Even modest retention improvements during the first weeks of treatment can significantly exceed the cost of pilot participation.
Note: This example is provided for illustration purposes only. Actual results will vary based on clinic size, program structure, and patient engagement patterns.
It's Structured Stabilization Monitoring
The RetentionHealth pilot introduces a stabilization support layer that operates alongside your existing GLP-1 program.
Your clinic continues running its current workflow.
RetentionHealth simply measures how stabilization support affects early-treatment retention.
RetentionHealth does not interfere with medical decision-making.
The pilot evaluates how structured stabilization monitoring affects patient engagement and retention.
RetentionHealth tracks:
Clinics receive weekly executive summaries that compare reinforced patient groups with the clinic's existing workflow baseline.
Structured Retention Validation
All pilot results are measured against your current program baseline, allowing clinics to quantify the operational impact of early-treatment stabilization.
The RetentionHealth pilot evaluates whether structured stabilization support improves early-treatment retention compared to your clinic's existing workflow.
During the pilot, clinics track two patient groups simultaneously.
Existing Workflow Group
Patients follow your clinic's normal onboarding and follow-up process.
Your current workflow continues unchanged.
Stabilization Group
Patients receive access to the RetentionHealth stabilization interface designed to support the early treatment ramp-up phase.
Access is delivered through a secure SMS link — no app download required.
The pilot compares outcomes between these two groups to measure the effect of structured stabilization support.
Once per week, clinics submit a small set of program-level metrics.
Typical metrics include:
Submission takes approximately 5 minutes per week.
No patient identifiers are submitted.
Clinics report simple aggregated counts only.
Each Monday, clinics receive a short executive summary that includes:
This allows clinics to observe stabilization patterns as the pilot progresses.
At the end of the pilot, RetentionHealth provides a structured validation review that quantifies:
All results are measured against your clinic's existing workflow baseline.
You can review both the clinic dashboard and the patient stabilization interface before applying for the pilot.
This preview allows you to see exactly how RetentionHealth monitors early-treatment stability and summarizes engagement signals for clinics.
Explore the Interfaces
Preview the system components used during the pilot.
See how clinics review stabilization signals, engagement trends, and weekly executive summaries.
Experience the patient-facing stabilization check-in and guidance interface used during the treatment ramp-up phase.
The pilot is intentionally lightweight.
One-time setup takes approximately 15 minutes.
After setup, most clinics spend less than 10 minutes per week participating.
Clinics receive pilot onboarding access and demo credentials.
Patients are assigned to two groups using your existing workflow:
No EMR integration required.
No workflow changes needed.
Patients begin their GLP-1 treatment ramp-up phase.
Patients in the stabilization group receive structured behavioral guidance through a secure SMS access link.
No app download required.
Clinics submit a short weekly report (≈5 minutes) including program-level metrics such as:
No patient identifiers are submitted.
Clinics report simple aggregated counts only.
RetentionHealth compiles stabilization trends and cohort comparisons from the pilot period.
Clinics receive a structured executive summary including:
Clinics then decide whether to continue into the full RetentionHealth platform.
The RetentionHealth pilot is intentionally structured to avoid handling Protected Health Information (PHI).
This allows clinics to participate without introducing additional regulatory overhead during the validation period.
The system operates without accessing or storing patient identifiers.
Because the pilot does not involve Protected Health Information (PHI), a Business Associate Agreement (BAA) is not required for pilot participation.
This design allows clinics to evaluate stabilization impact while minimizing compliance burden.
If the pilot validates measurable retention improvement, the full RetentionHealth platform will operate within a HIPAA-compliant infrastructure environment, including:
Limited to the First 6 Clinics
The RetentionHealth pilot is intentionally limited to a small cohort of six owner-led clinics.
This allows close collaboration during the initial stabilization validation phase.
Once the founder cohort is filled, founder pricing will not be offered again.
Clinics participating in the initial cohort receive:
RetentionHealth does not alter medical protocols or clinical authority.
At the end of the 8-week pilot, if measurable stabilization improvements are observed, participating clinics may convert to the production platform under their Founder terms.
The founder pilot cohort closes once 6 clinics are approved.
The founder pilot is designed for clinics that want to stabilize early-treatment retention in GLP-1 programs.
Participating clinics typically have:
The pilot is intentionally structured for independent clinics and is not designed for national franchise groups.
RetentionHealth is engineered and maintained by Dig Development, a software studio specializing in secure operational infrastructure, analytics systems, and platform architecture.
The system is designed to support clinic operations at scale, with a clear separation between pilot validation and the full production environment.
The pilot environment is intentionally structured to validate stabilization impact without handling Protected Health Information (PHI).
If the pilot demonstrates measurable retention improvements, the production platform will operate within a HIPAA-compliant infrastructure environment, including secure clinic environments and executed Business Associate Agreements (BAAs).
This staged architecture allows clinics to evaluate stabilization impact before introducing regulated healthcare data workflows.
Limited to 6 Clinics for Initial Validation
RetentionHealth is currently selecting a small group of clinics to participate in the 8-week stabilization pilot.
Applications are reviewed individually to ensure a strong fit.
Takes about 20 seconds • Reviewed within 48 hours
Clinics selected for the pilot will receive onboarding instructions and demo access immediately after approval.